Page 154 - TD-3-4
P. 154
Tumor Discovery Primarily enucleated RB patient’s analysis
33. Honavar SG, Singh AD, Shields CL, et al. Postenucleation Ophthalmology. 2015;122(6):1165-1172.
adjuvant therapy in high-risk retinoblastoma. Arch doi: 10.1016/J.Ophtha.2015.01.018
Ophthalmol. 2002;120(7):923-931.
35. Yahaya JJ, Rugwizangoga B, Mremi A, Munema A.
doi: 10.1001/Archopht.120.7.923 Clinicopathological findings of retinoblastoma: A 10-year
34. Kaliki S, Srinivasan V, Gupta A, Mishra DK, Naik MN. experience from a tertiary hospital in Kampala, Uganda.
Clinical features predictive of high-risk retinoblastoma J Ophthalmol. 2019;2019:5829284.
in 403 Asian Indian patients: A case-control study. doi: 10.1155/2019/5829284.
Volume 3 Issue 4 (2024) 11 doi: 10.36922/td.4336
